GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (STU:4RY) » Definitions » Deferred Policy Acquisition Costs

Akeso (STU:4RY) Deferred Policy Acquisition Costs


View and export this data going back to 2020. Start your Free Trial

What is Akeso Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Akeso Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Akeso Inc (STU:4RY) » Definitions » Deferred Policy Acquisition Costs
Traded in Other Exchanges
Address
No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in Mainland China, and also has its presence in USA and Other regions.